학술논문
Phase I Trial of 131 I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients
Document Type
Article
Author
Source
In: Journal of Nuclear Medicine . (Journal of Nuclear Medicine, 1 August 2021, 62(8):1097-1105)
Subject
Language
English
ISSN
2159662X
01615505
01615505